The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

"FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

Harvey Fierstein shared how he lost 120 pounds. He says he is a “great believer” in weight loss drugs like Zepbound and ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

( NewsNation) — The director of medical weight management at West Virginia University says a canceled pilot program that ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...